Back to Search
Start Over
Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
- Source :
-
Thrombosis research [Thromb Res] 2014 Aug; Vol. 134 (2), pp. 503-9. Date of Electronic Publication: 2014 May 29. - Publication Year :
- 2014
-
Abstract
- Introduction: Lupus anticoagulant (LA) is an antibody that interferes with one or more in vitro coagulation reactions, which are dependent on interactions with protein-phospholipid complexes. For LA diagnosis, a mixing test is considered useful for differentiating the inhibitor from a factor deficiency. However, the usefulness and the index of circulating anticoagulant (ICA) in a mixing test with activated partial thromboplastin time (APTT) has not been adequately investigated, and there is scant information regarding the effects of warfarin, heparin, and hemophilia plasma on ICA. We evaluated the usefulness of ICA by investigating the correlation of that index with international normalized ratio (INR), heparin concentration, and factor VIII activity in hemophilia patients.<br />Materials and Methods: We examined samples from 28 patients positive for LA, 23 receiving warfarin, 19 receiving unfractionated heparin, and 29 with hemophilia A, as well as 61 normal samples. APTT-SLA, Actin FSL, APTT-SP, and PTT-LA were used as reagents in this study.<br />Results: The correlation coefficient values between ICA and INR, heparin concentration, and factor VIII activity ranged from 0.031-0.342, 0.764-0.843, and 0.564-0.754, respectively, with the 4 reagents. The ICA values for the LA-positive samples were significantly higher than for the normal, warfarin, heparin, and hemophilia samples with all APTT reagents. Samples with a high heparin concentration above approximately 0.5U/ml showed ICA values greater than 15.<br />Conclusion: ICA was able to distinguish LA-positive samples from the normal, warfarin, and hemophilia samples, but not heparin samples. ICA calculated from APTT clotting time is useful for LA diagnosis.<br /> (Copyright © 2014 Elsevier Ltd. All rights reserved.)
- Subjects :
- Anticoagulants analysis
Anticoagulants therapeutic use
Antiphospholipid Syndrome blood
Factor VIII analysis
Hemophilia A blood
Heparin analysis
Heparin therapeutic use
Humans
Immunoglobulins analysis
International Normalized Ratio
Lupus Coagulation Inhibitor analysis
Sensitivity and Specificity
Warfarin analysis
Warfarin therapeutic use
Immunoglobulins blood
Lupus Coagulation Inhibitor blood
Partial Thromboplastin Time methods
Subjects
Details
- Language :
- English
- ISSN :
- 1879-2472
- Volume :
- 134
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Thrombosis research
- Publication Type :
- Academic Journal
- Accession number :
- 24935674
- Full Text :
- https://doi.org/10.1016/j.thromres.2014.05.030